Market Place
Sourcing Support
Alopexx Collaborates With Bharat Biotech On Vaccine AV0328
10 Sep 2024 //
GLOBENEWSWIRE
Bharat Biotech Launches Oral Cholera Vaccine Hillchol After Phase 3 Trial
27 Aug 2024 //
REUTERS
Bharat Biotech Added ICMR, NIV As Covaxin Co-Inventors After Delay
01 Aug 2024 //
ECONOMICTIMES
Indian drugmakers seek govt tax reliefs, incentives to spur innovation
06 Jul 2024 //
REUTERS
Bharat Bio`s Rotavirus vaccine Rotavac may be unsafe for children: Study
16 Jun 2024 //
ECONOMICTIMES
Adverse events seen in some participants who took Covaxin, reports new study
16 May 2024 //
ECONOMICTIMES
Bharat Biotech, Bilthoven collaborate for oral polio vaccines production, supply
02 Apr 2024 //
ECONOMICTIMES
Bharat Biotech begins clinical trials of TB vaccine on adults in India
24 Mar 2024 //
ECONOMIC TIMES
Bharat signs MoU with University of Sydney to collaborate on vaccine research
28 Nov 2023 //
ECONOMIC TIMES
Bharat Biotech picks up 20 per cent stake in Eastman Exports Global Clothing
27 Jul 2023 //
ECONOMIC TIMES
Big private hospitals aren`t stocking up on nasal vaccine amid poor demand
16 Feb 2023 //
ECONOMIC TIMES
3 lakh doses of intranasal Covid vaccine sent to hospitals
05 Feb 2023 //
ECONOMIC TIMES
Bharat Biotech`s nasal Covid vaccine iNCOVACC launched
26 Jan 2023 //
ECONOMIC TIMES
Incovacc, World`s first nasal vaccine, in private hospitals from next week
26 Jan 2023 //
ECONOMIC TIMES
Bharat Biotech subsidiary recalls rabies vaccine batch after theft
23 Jan 2023 //
THEHINDU
First Indian intranasal Covid vaccine to be launched on Jan 26
22 Jan 2023 //
ECONOMIC TIMES
Bharat founder bats for incentives, tax breaks for patented products
20 Jan 2023 //
ECONOMIC TIMES
Govt may not procure Bharat Biotech`s intranasal Covid vaccine iNNOVACC
17 Jan 2023 //
ECONOMIC TIMES
Covaxin well tolerated in those not yet vaccinated in US: Study
10 Jan 2023 //
ECONOMIC TIMES
Ocugen-Bharat Biotech COVID vaccine meets main goals in U.S. trial
10 Jan 2023 //
REUTERS
World`s first intranasal vaccine iNCOVACC will be rolled out in the 4th w of Jan
29 Dec 2022 //
INDIANPHARMAPOST
Zydus’ Covid vax ZyCoV-D falls behind as pace picks up for precautionary doses
29 Dec 2022 //
THEHINDUBUSINESSLINE
Biological E, Bharat Biotech together sitting on stockpile of 250 m COVID doses
27 Dec 2022 //
ECONOMIC TIMES
BF.7 boosters still in lab stage, Bharat Biotech to begin incubation
24 Dec 2022 //
ECONOMICTIMES
Bharat Biotech`s intranasal Covid vaccine approved, to be available on CO-WIN
23 Dec 2022 //
ECONOMICTIMES
India’s CDSCO approves Bharat Biotech’s intra-nasal vaccine for Covid-19
02 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Bharat Biotech’s intranasal vaccine ‘iNCOVACC’ receives CDSCO approval
29 Nov 2022 //
ECONOMIC TIMES
DCGI nod to Bharat Biotech`s Intranasal Covid booster dose for restricted use
25 Nov 2022 //
HEALTH ET
There was no pressure to speed up Covaxin, norms followed: Bharat Biotech
17 Nov 2022 //
HEALTH ET
Over 200m doses of Covaxin set to expire
03 Nov 2022 //
ECONOMICTIMES
PLI schemes should focus on entities supporting production of pharma products
25 Sep 2022 //
HEALTH ET
SEC to review Bharat Bio`s intranasal jab for use as booster soon
21 Sep 2022 //
HEALTH ET
Bharat seeks DCGI nod for phase-3 study of intranasal Covid vaccine
11 Sep 2022 //
ECONOMIC TIMES
DCGI nod sought for phase-3 study of intranasal Covid vax in 5-18 age group
11 Sep 2022 //
BUSINESS-STANDARD
Bharat Biotech`s COVID-19 nasal vaccine approved for restricted use in India
07 Sep 2022 //
REUTERS
Clinical data disclosure critical for success of Bharat Bio`s Covid-19 vaccine
26 Aug 2022 //
PHARMABIZ
Bharat Biotech seeks nod for intranasal Covid vaccine
15 Aug 2022 //
ECONOMIC TIMES
India to start COVID mix-and-match booster vaccines on Friday
10 Aug 2022 //
REUTERS
Covaxin booster dose approved by Japan, says Bharat Biotech
05 Aug 2022 //
ECONOMIC TIMES
Bharat Biotech expects regulator`s nod for intranasal COVID-19 vaccine in August
02 Aug 2022 //
ECONOMIC TIMES
Excellgene partners with Bharat Biotech for variant proof Covid vaccine
26 Jul 2022 //
ECONOMIC TIMES
NTAGI likely to discuss soon data of India`s first mRNA vaccine against Covid
11 Jul 2022 //
ECONOMIC TIMES
Bharat Biotech`s Zika vaccine to enter Phase 2 clinical trials soon
10 Jul 2022 //
BUSINESS-STANDARD
NTAGI to decide on including Corbevax as a booster dose in inoculation drive
08 Jul 2022 //
ECONOMIC TIMES
Allowing Corbevax as booster for those vaccinated with Covishield, Covaxin
28 Jun 2022 //
ECONOMIC TIMES
Ocugen announces positive results for COVID-19 vaccine trial in 2-18 years
22 Jun 2022 //
EXPRESS PHARMA
Bharat Biotech`s Covid-19 nasal vaccine phase III trials completed
19 Jun 2022 //
ECONOMIC TIMES
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
17 Jun 2022 //
ECONOMIC TIMES
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
15 Jun 2022 //
NDTV
NTAGI may soon review efficacy data of India`s first intranasal Covid vaccine
03 Jun 2022 //
ECONOMIC TIMES
FDA lifts hold on Covaxin`s clinical trials in US
25 May 2022 //
ET HEALTH
Covaxin`s clinical trials can resume in US as FDA lifts hold
25 May 2022 //
ECONOMIC TIMES
CEPI partners consortium of Bharat Biotech, University of Sydney, ExcellGene
11 May 2022 //
EXPRESS PHARMA
CEPI partners BB consortium to develop variant-proof Covid vaccine
10 May 2022 //
TIMESOFINDIA
Bharat Biotech International on Health Canada Inspection List
09 May 2022 //
HEALTH CANADA
Bharat Biotech seeks DCGI nod for PII/III Covaxin booster trial among 2-18 Years
04 May 2022 //
ECONOMIC TIMES
Bharat Biotech must address WHO`s Covaxin suspension to avoid EUL cancellation
29 Apr 2022 //
ECONOMIC TIMES
Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin
22 Apr 2022 //
ECONOMICTIMES
Manufacturing problems trigger clinical hold for troubled Covid-19 vaccine
13 Apr 2022 //
ENDPTS
Manufacturing problems trigger clinical hold for troubled Covid-19 vaccine
12 Apr 2022 //
ENDPTS
